Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025
Report Code: KNJ00100
Publisher: Date of Publish:
No. of Pages: 115 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
The global 27 cancer blockbuster drugs market size is set to surpass US$ 120 billion by 2025. “Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025” presents an in-depth assessment of the global cancer blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for global cancer blockbuster drugs market. The report includes historical data from 2015 to 2018 and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the global cancer blockbuster drugs market. The report explores detailed analysis of top 27 drugs market assessment globally from 2015 to 2018 and forecasts to 2025. Key trends in terms of collaboration, merger & acquisition, partnerships, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global cancer blockbuster drugs market. The report concludes with the profiles of major players in the global cancer blockbuster drugs market. The key market players are evaluated on various parameters such as business overview and recent development. The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are: 1. Roche 2. Bristol-Myers Squibb 3. Pfizer 4. Eli Lilly and Company 5. Merck 6. Johnson & Johnson 7. AstraZeneca 8. Celgene 9. Novartis 10. Amgen Top 27 Cancer Blockbuster Drugs Covered Under This Report Are: 1. Imbruvica 2. Revlimid 3. Pomalyst/Imnovid 4. Keytruda 5. Herceptin 6. Avastin 7. MabThera/Rituxan 8. Perjeta 9. Opdivo 10. Sprycel 11. Ibrance 12. Zytiga 13. Tagrisso 14. Darzalex 15. Xtandi 16. Jakafi/Jakavi 17. Yervoy 18. Alimta 19. Gleevec/Glivec 20. Velcade 21. Tasigna 22. Xgeva 23. Afinitor/Votubia 24. Neulasta 25. Exjade Jadenu 26. Sandostatin 27. Faslodex The Latest Industry Data Included in this Report: Global Top 27 Cancer Blockbuster Drugs Market Size & Analysis (2015 – 2025) Global Top 27 Cancer Blockbuster Drugs Market Share & Y–o–Y Growth (%), 2015 – 2025 Global Top 27 Cancer Blockbuster Drugs Market Assessment & Opportunity, (2015 – 2025) Major Deals (Mergers, Acquisitions, Key Agreements, Partnerships & Collaborations) Key Market Drivers and Inhibitors of the Global Cancer Blockbuster Drugs Market Major Companies Analysis The Report Answers the Following Questions about the Global Cancer Blockbuster Drugs Market: What is the size of the global top 27 cancer blockbuster drugs market during 2015 -2025? What will be the revenue generated by each drug during the forecast period? Which major drugs provides highest market share? How are the overall market and major drugs growing? What are the key drivers and inhibitors in the current market? What will be the impact of drivers and inhibitors in the future? How is the market predicted to develop in the future? Who are the key players in this market space?
1. Executive Summary 2. Global Top 27 Cancer Blockbuster Drugs Market Size & Analysis (2015 – 2025) 3. Global Top 27 Cancer Blockbuster Drugs Market Share & Y–o–YGrowth (%), 2015 – 2025 4. Key Drivers and Inhibitors of the Global Cancer Blockbuster Drugs Market 4.1 Market Drivers 4.2 Market Inhibitors 5. Global Top 27 Cancer Blockbuster Drugs Market Assessment & Opportunity, (2015 – 2025) 5.1 Imbruvica (Ibrutinib) 5.2 Revlimid (Lenalidomide) 5.3 Pomalyst/Imnovid (Pomalidomide) 5.4 Keytruda (Pembrolizumab) 5.5 Herceptin (Trastuzumab) 5.6 Avastin (Bevacizumab) 5.7 MabThera/Rituxan (Rituximab) 5.8 Perjeta (Pertuzumab) 5.9 Opdivo (Nivolumab) 5.10 Sprycel (Dasatinib) 5.11 Ibrance (Palbociclib) 5.12 Zytiga (Abiraterone acetate) 5.13 Tagrisso (Osimertinib) 5.14 Darzalex (Daratumumab) 5.15 Xtandi (Enzalutamide) 5.16 Jakafi/Jakavi (Ruxolitinib Phosphate) 5.17 Yervoy (Ipilimumab) 5.18 Alimta (Pemetrexed) 5.19 Gleevec/Glivec (Imatinib Mesylate) 5.20 Velcade (Bortezomib) 5.21 Tasigna (Nilotinib) 5.22 Xgeva (Denosumab) 5.23 Afinitor/Votubia (Everolimus) 5.24 Neulasta (Pegfilgrastim) 5.25 Exjade Jadenu (Deferasirox) 5.26 Sandostatin (Octreotide Acetate) 5.27 Faslodex (Fulvestrant) 6. Major Deals in Cancer Drugs Market 6.1 Collaboration Deals 6.2 Merger and Acquisitions 6.3 Licensing Agreement 6.4 Partnership Deals 6.5 Distribution Agreement 7. Key Companies Analysis 7.1 Roche 7.1.1 Business Overview 7.1.2 Recent Development 7.2 Bristol-Myers Squibb 7.2.1 Business Overview 7.2.2 Recent Development 7.3 Pfizer 7.3.1 Business Overview 7.3.2 Recent Development 7.4 Eli Lilly and Company 7.4.1 Business Overview 7.4.2 Recent Development 7.5 Merck 7.5.1 Business Overview 7.5.2 Recent Development 7.6 Johnson & Johnson 7.6.1 Business Overview 7.6.2 Recent Development 7.7 AstraZeneca 7.7.1 Business Overview 7.7.2 Recent Development 7.8 Celgene 7.8.1 Business Overview 7.8.2 Recent Development 7.9 Novartis 7.9.1 Business Overview 7.9.2 Recent Developmnet 7.10 Amgen 7.10.1 Business Overview 7.10.2 Recent Development List of Tables Table 3–1: Global Top 27 Cancer Blockbuster Drugs Market Share & Y–o–Y Growth (%), 2015 – 2018 Table 3–2: Global Top 27 Cancer Blockbuster Drugs Market Share & Y–o–Y Growth Forecast (%), 2019 – 2025 Table 7–1: Collaboration Deals in Cancer Drugs Market Table 7–2: Merger and Acquisitions in Cancer Drugs Market Table 7–3: Licensing Agreement in Cancer Drugs Market Table 7–4: Partnership Deals in Cancer Drugs Market Table 7–5: Distribution Agreement in Cancer Drugs Market List of Figures Figure 2–1: Global Top 27 Cancer Blockbuster Drugs Market Size (Million US$),2015 – 2018 Figure 2–2: Global Top 27 Cancer Blockbuster Drugs Market Size Forecast (Million US$),2019 – 2025 Figure 4–1: Global Ageing Population & Forecast (Million), 2010 – 2050 Figure 5–1: Global Imbruvica Market Value (Million US$),2015 – 2018 Figure 5–2: Global Imbruvica Market Value Forecast (Million US$),2019 – 2025 Figure 5–3: Global Revlimid Market Value (Million US$),2015 – 2018 Figure 5–4: Global Revlimid Market Value Forecast (Million US$),2019 – 2025 Figure 5–5: Global Pomalyst/Imnovid Market Value (Million US$),2015 – 2018 Figure 5–6: Global Pomalyst/Imnovid Market Value Forecast (Million US$),2019 – 2025 Figure 5–7: Global Keytruda Market Value (Million US$),2015 – 2018 Figure 5–8: Global Keytruda Market Value Forecast (Million US$),2019 – 2025 Figure 5–9: Global Herceptin Market Value (Million US$),2015 – 2018 Figure 5–10: Global Herceptin Market Value Forecast (Million US$),2019 – 2025 Figure 5–11: Global Avastin Market Value (Million US$),2015 – 2018 Figure 5–12: Global Avastin Market Value Forecast (Million US$),2019 – 2025 Figure 5–13: Global MabThera/Rituxan Market Value (Million US$),2015 – 2018 Figure 5–14: Global MabThera/Rituxan Market Value Forecast (Million US$),2019 – 2025 Figure 5–15: Global Perjeta Market Value (Million US$),2015 – 2018 Figure 5–16: Global Perjeta Market Value Forecast (Million US$),2019 – 2025 Figure 5–17: Global Opdivo Market Value (Million US$),2015 – 2018 Figure 5–18: Global Opdivo Market Value Forecast (Million US$),2019 – 2025 Figure 5–19: Global Sprycel Market Value (Million US$),2015 – 2018 Figure 5–20: Global Sprycel Market Value Forecast (Million US$),2019 – 2025 Figure 5–21: Global Ibrance Market Value (Million US$),2015 – 2018 Figure 5–22: Global Ibrance Market Value Forecast (Million US$),2019 – 2025 Figure 5–23: Global Zytiga Market Value (Million US$),2015 – 2018 Figure 5–24: Global Zytiga Market Value Forecast (Million US$),2019 – 2025 Figure 5–25: Global Tagrisso Market Value (Million US$),2015 – 2018 Figure 5–26: Global Tagrisso Market Value Forecast (Million US$),2019 – 2025 Figure 5–27: Global Darzalex Market Value (Million US$),2015 – 2018 Figure 5–28: Global Darzalex Market Value Forecast (Million US$),2019 – 2025 Figure 5–29: Global Xtandi Market Value (Million US$),2015 – 2018 Figure 5–30: Global Xtandi Market Value Forecast (Million US$),2019 – 2025 Figure 5–31: Global Jakafi/Jakavi Market Value (Million US$),2015 – 2018 Figure 5–32: Global Jakafi/Jakavi Market Value Forecast (Million US$),2019 – 2025 Figure 5–33: Global Yervoy Market Value (Million US$),2015 – 2018 Figure 5–34: Global Yervoy Market Value Forecast (Million US$),2019 – 2025 Figure 5–35: Global Alimta Market Value (Million US$),2015 – 2018 Figure 5–36: Global Alimta Market Value Forecast (Million US$),2019 – 2025 Figure 5–37: Global Gleevec/Glivec Market Value (Million US$),2015 – 2018 Figure 5–38: Global Gleevec/Glivec Market Value Forecast (Million US$),2019 – 2025 Figure 5–39: Global Velcade Market Value (Million US$),2015 – 2018 Figure 5–40: Global Velcade Market Value Forecast (Million US$),2019 – 2025 Figure 5–41: Global Tasigna Market Value (Million US$),2015 – 2018 Figure 5–42: Global Tasigna Market Value Forecast (Million US$),2019 – 2025 Figure 5–43: Global Xgeva Market Value (Million US$),2015 – 2018 Figure 5–44: Global Xgeva Market Value Forecast (Million US$),2019 – 2025 Figure 5–45: Global Afinitor/Votubia Market Value (Million US$),2015 – 2018 Figure 5–46: Global Afinitor/Votubia Market Value Forecast (Million US$),2019 – 2025 Figure 5–47: Global Neulasta Market Value (Million US$),2015 – 2018 Figure 5–48: Global Neulasta Market Value Forecast (Million US$),2019 – 2025 Figure 5–49: Global Exjade Jadenu Market Value (Million US$),2015 – 2018 Figure 5–50: Global Exjade Jadenu Market Value Forecast (Million US$),2019 – 2025 Figure 5–51: Global Sandostatin Market Value (Million US$),2015 – 2018 Figure 5–52: Global Sandostatin Market Value Forecast (Million US$),2019 – 2025 Figure 5–53: Global Faslodex Market Value (Million US$),2015 – 2018 Figure 5–54: Global Faslodex Market Value Forecast (Million US$),2019 – 2025
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com